I

ImmunoGen, Inc.

366 employees

ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Heme malignancies
ADCs
Ovarian cancer
Medical
Health Care
BPDCN
AML
Antibody-drug conjugates

Date founded

1981

Funding rounds raised

Total raised

$75M

from 1 investors over 1 rounds

I

ImmunoGen, Inc. raised $75M on April 6, 2023

Investors: Pharmakon Advisors, LP

FAQ